Download Docs
Export

Altered ERCC1 expression correlates with response to cisplatin (DDP) and gemcitabine efficacy in non-small-cell lung cancer (NSCLC) patients

60/250,121 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Date # Transaction
More information is available to registered Docket Alarm users.